XAGE2
gene geneOn this page
Also known as XAGE-2CT12.2
Summary
XAGE2 (X antigen family member 2, HGNC:4112) is a protein-coding gene on chromosome Xp11.22, encoding X antigen family member 2 (Q96GT9).
This gene is a member of the XAGE subfamily, which belongs to the GAGE family. The GAGE genes are expressed in a variety of tumors and in some fetal and reproductive tissues. This gene is strongly expressed in normal testis, and in Ewing’s sarcoma, rhabdomyosarcoma, a breast cancer and a germ cell tumor. The protein encoded by this gene shares a sequence similarity with other GAGE/PAGE proteins. Because of the expression pattern and the sequence similarity, this protein also belongs to a family of CT (cancer-testis) antigens.
Source: NCBI Gene 9502 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_130777
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4112 |
| Approved symbol | XAGE2 |
| Name | X antigen family member 2 |
| Location | Xp11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | XAGE-2, CT12.2 |
| Ensembl gene | ENSG00000155622 |
| Ensembl biotype | protein_coding |
| OMIM | 300416 |
| Entrez | 9502 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000286049, ENST00000962144, ENST00000962145, ENST00000962146
RefSeq mRNA: 1 — MANE Select: NM_130777
NM_130777
CCDS: CCDS59525
Canonical transcript exons
ENST00000286049 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001631419 | 52370007 | 52370095 |
| ENSE00001637310 | 52370567 | 52370672 |
| ENSE00001675516 | 52369021 | 52369214 |
| ENSE00001788507 | 52372544 | 52372669 |
| ENSE00001911244 | 52375569 | 52375680 |
Expression profiles
Bgee: expression breadth broad, 51 present calls, max score 94.16.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.7196 / max 752.2440, expressed in 78 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201295 | 1.8426 | 59 |
| 196391 | 0.7816 | 45 |
| 209689 | 0.0955 | 22 |
Top tissues by expression
186 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| placenta | UBERON:0001987 | 94.16 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.93 | gold quality |
| decidua | UBERON:0002450 | 84.05 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.08 | gold quality |
| tibialis anterior | UBERON:0001385 | 76.35 | silver quality |
| pancreatic ductal cell | CL:0002079 | 76.29 | silver quality |
| amniotic fluid | UBERON:0000173 | 75.19 | silver quality |
| deltoid | UBERON:0001476 | 74.38 | gold quality |
| cerebellar vermis | UBERON:0004720 | 71.52 | gold quality |
| cartilage tissue | UBERON:0002418 | 70.32 | gold quality |
| myocardium | UBERON:0002349 | 70.31 | gold quality |
| gingival epithelium | UBERON:0001949 | 70.17 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 69.64 | gold quality |
| ileal mucosa | UBERON:0000331 | 69.49 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 69.46 | gold quality |
| pericardium | UBERON:0002407 | 68.16 | silver quality |
| body of tongue | UBERON:0011876 | 67.06 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 67.01 | gold quality |
| cardia of stomach | UBERON:0001162 | 66.97 | gold quality |
| vena cava | UBERON:0004087 | 66.79 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 66.77 | gold quality |
| pylorus | UBERON:0001166 | 66.76 | gold quality |
| thymus | UBERON:0002370 | 66.62 | silver quality |
| substantia nigra pars reticulata | UBERON:0001966 | 66.55 | gold quality |
| biceps brachii | UBERON:0001507 | 66.50 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 66.36 | gold quality |
| trachea | UBERON:0003126 | 66.30 | silver quality |
| pons | UBERON:0000988 | 66.29 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 66.29 | gold quality |
| gingiva | UBERON:0001828 | 66.26 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6701 | yes | 1983.74 |
| E-MTAB-3929 | yes | 85.68 |
| E-MTAB-6678 | yes | 16.78 |
| E-ANND-3 | no | 2.11 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (22): PAGE1 (ENSG00000068985), PAGE4 (ENSG00000101951), PAGE5 (ENSG00000158639), XAGE3 (ENSG00000171402), XAGE5 (ENSG00000171405), GAGE2A (ENSG00000189064), PAGE3 (ENSG00000204279), XAGE1A (ENSG00000204379), XAGE1B (ENSG00000204382), GAGE1 (ENSG00000205777), GAGE12G (ENSG00000215269), GAGE10 (ENSG00000215274), GAGE12E (ENSG00000216649), GAGE12J (ENSG00000224659), GAGE12H (ENSG00000224902), GAGE12D (ENSG00000227488), PAGE2 (ENSG00000234068), GAGE12F (ENSG00000236362), GAGE12C (ENSG00000237671), PAGE2B (ENSG00000238269), GAGE13 (ENSG00000274274), GAGE2E (ENSG00000275113)
Protein
Protein identifiers
X antigen family member 2 — Q96GT9 (reviewed: Q96GT9)
Alternative names: Cancer/testis antigen 12.2, G antigen family D member 3
All UniProt accessions (1): Q96GT9
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GAGE family.
RefSeq proteins (1): NP_570133* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008625 | GAGE_fam | Family |
| IPR031320 | GAGE | Domain |
Pfam: PF05831
UniProt features (4 total): region of interest 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96GT9-F1 | 64.59 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, chrXp11, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, YAP1_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
232 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| XAGE2 | XAGE1B | Q9HD64 | 923 |
| XAGE2 | SPANXD | Q9BXN6 | 570 |
| XAGE2 | SPANXC | Q9NY87 | 570 |
| XAGE2 | ERVV-1 | B6SEH8 | 448 |
| XAGE2 | SPANXB1 | Q9NS25 | 447 |
| XAGE2 | SPANXA1 | Q9NS26 | 447 |
| XAGE2 | MAGEA12 | P43365 | 413 |
| XAGE2 | CT45A1 | Q5HYN5 | 402 |
| XAGE2 | MAGEB2 | O15479 | 397 |
| XAGE2 | DNAJB8 | Q8NHS0 | 379 |
| XAGE2 | CGB5 | P01233 | 377 |
| XAGE2 | TEX15 | Q9BXT5 | 377 |
| XAGE2 | MAGEA4 | P43358 | 373 |
| XAGE2 | NBPF4 | Q96M43 | 372 |
| XAGE2 | DKKL1 | Q9UK85 | 370 |
| XAGE2 | SPA17 | Q15506 | 370 |
IntAct
20 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| XAGE2 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.770 |
| GMCL1 | XAGE2 | psi-mi:“MI:0915”(physical association) | 0.770 |
| FLJ13057 | XAGE2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GMCL2 | XAGE2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| XAGE2 | GMCL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| XAGE2 | EHMT2 | psi-mi:“MI:0915”(physical association) | 0.550 |
| XAGE2 | WIZ | psi-mi:“MI:0914”(association) | 0.530 |
| TERF2IP | XAGE2 | psi-mi:“MI:0915”(physical association) | 0.510 |
| EPS8 | XAGE2 | psi-mi:“MI:0915”(physical association) | 0.490 |
| XAGE2 | EPS8 | psi-mi:“MI:0915”(physical association) | 0.490 |
| XAGE2 | POT1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TERF2IP | XAGE2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| XAGE2 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (23): GMCL1 (Two-hybrid), GMCL1P1 (Two-hybrid), EHMT2 (Two-hybrid), XAGE2 (Two-hybrid), XAGE2 (Two-hybrid), WIZ (Affinity Capture-MS), EHMT2 (Affinity Capture-MS), ZNF644 (Affinity Capture-MS), EHMT1 (Affinity Capture-MS), GMCL1 (Affinity Capture-MS), CBX5 (Affinity Capture-MS), XAGE2 (Two-hybrid), WIZ (Affinity Capture-MS), GMCL1 (Affinity Capture-MS), EHMT1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GTR3, A0A7H0DN82, A7RR34, E9PVX6, O14598, O60356, O60829, O94243, P04605, P04614, P05909, P0C1K0, P0C765, P0C766, P0DPH9, P17285, P17759, P18098, P19416, P20290, P24109, P46012, P46583, Q06428, Q07555, Q08561, Q09821, Q1L9C7, Q32PF3, Q3KP22, Q5M948, Q5M951, Q5MJ08, Q5RCI9, Q6P8I4, Q758T8, Q76632, Q7M2N1, Q7TP40, Q80WR5
Diamond homologs: A1L429, A6NDE8, A6NER3, A6NGK3, O75459, O76087, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, Q13066, Q13069, Q13070, Q4V321, Q4V326, Q6NT46, Q8WTP9, Q96GT9, Q9UEU5, Q8WWM1, Q5JUK9, Q5JRK9, Q7Z2X7, Q96GU1, Q9HD64
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
684 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:52370092:GCTT:G | donor_gain | 1.0000 |
| X:52370096:G:GG | donor_gain | 1.0000 |
| X:52370540:A:AG | acceptor_gain | 1.0000 |
| X:52370541:C:G | acceptor_gain | 1.0000 |
| X:52370542:A:AG | acceptor_gain | 1.0000 |
| X:52370543:C:G | acceptor_gain | 1.0000 |
| X:52370544:A:AG | acceptor_gain | 1.0000 |
| X:52370544:ATACT:A | acceptor_gain | 1.0000 |
| X:52370545:T:G | acceptor_gain | 1.0000 |
| X:52370546:A:AG | acceptor_gain | 1.0000 |
| X:52370546:ACT:A | acceptor_gain | 1.0000 |
| X:52370548:T:A | acceptor_gain | 1.0000 |
| X:52370562:CCCA:C | acceptor_loss | 1.0000 |
| X:52370563:CCAG:C | acceptor_loss | 1.0000 |
| X:52370564:CAGGA:C | acceptor_loss | 1.0000 |
| X:52370565:A:AG | acceptor_gain | 1.0000 |
| X:52370566:G:GA | acceptor_loss | 1.0000 |
| X:52370566:G:GG | acceptor_gain | 1.0000 |
| X:52370661:C:G | donor_gain | 1.0000 |
| X:52370668:TCAAG:T | donor_loss | 1.0000 |
| X:52370669:CAAGG:C | donor_loss | 1.0000 |
| X:52370671:AG:A | donor_loss | 1.0000 |
| X:52370672:GGTG:G | donor_loss | 1.0000 |
| X:52370673:G:C | donor_loss | 1.0000 |
| X:52370681:A:T | donor_gain | 1.0000 |
| X:52370685:G:GT | donor_gain | 1.0000 |
| X:52370686:A:T | donor_gain | 1.0000 |
| X:52372540:TTA:T | acceptor_loss | 1.0000 |
| X:52372541:TAGT:T | acceptor_loss | 1.0000 |
| X:52372542:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
719 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:52370032:A:C | R6S | 0.697 |
| X:52370032:A:T | R6S | 0.697 |
| X:52370027:G:A | G5R | 0.636 |
| X:52370027:G:C | G5R | 0.636 |
| X:52370023:G:C | W3C | 0.633 |
| X:52370023:G:T | W3C | 0.633 |
| X:52370021:T:A | W3R | 0.631 |
| X:52370021:T:C | W3R | 0.631 |
| X:52370044:G:C | R10S | 0.601 |
| X:52370044:G:T | R10S | 0.601 |
| X:52370022:G:T | W3L | 0.587 |
| X:52370028:G:A | G5E | 0.578 |
dbSNP variants (sampled 300 via entrez): RS1001102424 (X:52371842 C>T), RS1001161064 (X:52371361 C>T), RS1001557594 (X:52367622 A>G), RS1001610082 (X:52367246 G>A), RS1001817154 (X:52375477 C>T), RS1002113603 (X:52373834 A>G), RS1002120946 (X:52375921 T>C), RS1002558895 (X:52369278 C>A), RS1002570792 (X:52373324 T>A,C), RS1002611020 (X:52369013 C>A), RS1004911376 (X:52371264 C>T), RS1004963569 (X:52370955 T>C), RS1005580765 (X:52375291 C>A,T), RS1005631849 (X:52374981 G>T), RS1005911647 (X:52373221 T>A)
Disease associations
OMIM: gene MIM:300416 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, increases methylation | 3 |
| mercuric bromide | affects cotreatment, increases expression | 2 |
| terbufos | increases methylation | 1 |
| sulforaphane | decreases expression | 1 |
| cobaltous chloride | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arbutin | increases expression | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Phenylmercuric Acetate | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Cyclosporine | increases methylation | 1 |
| Sodium Selenite | decreases expression | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.